全文获取类型
收费全文 | 4222篇 |
免费 | 288篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 10篇 |
妇产科学 | 67篇 |
基础医学 | 309篇 |
口腔科学 | 58篇 |
临床医学 | 339篇 |
内科学 | 323篇 |
皮肤病学 | 21篇 |
神经病学 | 74篇 |
特种医学 | 253篇 |
外国民族医学 | 13篇 |
外科学 | 367篇 |
综合类 | 266篇 |
预防医学 | 167篇 |
眼科学 | 31篇 |
药学 | 175篇 |
1篇 | |
中国医学 | 17篇 |
肿瘤学 | 2040篇 |
出版年
2024年 | 12篇 |
2023年 | 227篇 |
2022年 | 278篇 |
2021年 | 258篇 |
2020年 | 280篇 |
2019年 | 193篇 |
2018年 | 102篇 |
2017年 | 126篇 |
2016年 | 161篇 |
2015年 | 207篇 |
2014年 | 312篇 |
2013年 | 248篇 |
2012年 | 275篇 |
2011年 | 275篇 |
2010年 | 218篇 |
2009年 | 245篇 |
2008年 | 111篇 |
2007年 | 230篇 |
2006年 | 208篇 |
2005年 | 167篇 |
2004年 | 109篇 |
2003年 | 78篇 |
2002年 | 73篇 |
2001年 | 41篇 |
2000年 | 27篇 |
1999年 | 21篇 |
1998年 | 22篇 |
1997年 | 6篇 |
1996年 | 14篇 |
1995年 | 11篇 |
1994年 | 11篇 |
1993年 | 9篇 |
1992年 | 7篇 |
1991年 | 3篇 |
1990年 | 4篇 |
1989年 | 3篇 |
1988年 | 8篇 |
1987年 | 1篇 |
排序方式: 共有4581条查询结果,搜索用时 218 毫秒
101.
Chen Linbin Li Yin Gao Xiaoyan Lin Shiyong He Longjun Luo Guangyu Li Jianjun Huang Chunyu Wang Guobao Yang Qing Shan Hongbo 《Digestive diseases and sciences》2021,66(8):2763-2775
Digestive Diseases and Sciences - Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is increasingly being used for diagnosing lymphadenopathy. We aim to systematically review the... 相似文献
102.
103.
《Vaccine》2015,33(26):2978-2983
Shigellosis or bacillary dysentery is endemic worldwide and is a significant cause of death in children less than five years of age in developing countries. There are no licensed Shigella vaccines and glycoconjugates are among the leading candidate vaccines against shigellosis today.We used whole genome sequence analysis (WGA) to find out whether immunization, with an investigational Shigella sonnei glycoconjugate, could induce selective pressure leading to changes in the genome of S. sonnei. An outbreak of culture-proven S. sonnei shigellosis which occurred immediately after vaccination in one of the cohorts of volunteers participating in a phase III trial of the vaccine in Israel created a unique condition in which the epidemic agent “co-existed” with the developing immune responses induced by the vaccine and natural infection among vaccinees who developed S. sonnei shigellosis. By comparing the whole genomes of S. sonnei isolated from vaccinees and from volunteers in the control group, we show at a very high sensitivity that a potent S. sonnei glycoconjugate that conferred 74% protective efficacy against the homologous disease did not induce changes in the genome of S. sonnei and in particular on the O-antigen gene cluster. 相似文献
104.
In China interventional therapy of liver cancer started in the 1980s. It is well-known that Professor Lin Gui is the founding father of Interventional radiology. Under the leadership of Lin Gui and other professors, interventional therapy of liver cancer has swiftly progressed in China. Indeed, TAI, TAE, TACE and ablation therapy have witnessed great innovations in hardware facilities, technical means, and therapeutic philosophy, while incorporating Chinese characteristics. As with the development of combined interventional therapy in China, interventional treatment of liver cancer has gradually started the process of precision and individualization. Actually, multidisciplinary, multimodal, and polymorphic treatments will be the most suitable pattern for liver cancer in the future, among which combination of interventional therapy with targeted, immunological treatments and information technology (IT) tools may bring a revolutionary breakthrough in liver cancer treatment. 相似文献
105.
目的探讨经皮射频消融(RFA)联合肝动脉栓塞化疗(TACE)序贯性治疗结直肠癌肝转移瘤的疗效。方法分析2006-06~2010-06开平市中心医院62例无法手术切除的结直肠癌肝转移瘤患者,按治疗方法分为2组:联合组(RFA联合TACE)34例,TACE组28例。观察治疗后第1周肝功能变化;治疗后4周增强CT/MRI检查肿瘤坏死率的情况;治疗后的生存率。结果 TACE组和联合组比较:1周后肝功能变化,差异无统计学意义(P>0.05);治疗后肿瘤坏死率分别为60.7%(17/28)和90.41%(32/34),差异有统计学意义(P<0.05);半年生存率分别为92.9%和97.1%,1,2,3年生存率联合组明显优于TACE组(P<0.05)。结论对于无法手术切除的结直肠癌肝转移瘤,射频消融联合肝动脉栓塞化疗的治疗效果明显优于肝动脉栓塞化疗,且安全可靠,易于操作。 相似文献
106.
Min-Shan?Lu Yu-Jing?Fang Yu-Ming?Chen Wei-Ping?Luo Zhi-Zhong?Pan Xiao?Zhong Cai-Xia?ZhangEmail author 《European journal of nutrition》2015,54(4):619-628
Purpose
The associations between specific carotenoid intake and colorectal cancer risk remain inconsistent. The aim of this study was to examine the association between specific dietary carotenoid intake with colorectal cancer risk in Chinese adults.Method
From July 2010 to October 2013, 845 eligible colorectal cancer cases and 845 frequency-matched controls (age and sex) completed in-person interviews. A validated food frequency questionnaire was used to estimate dietary intake. Multivariate logistical regression models were used to calculate the odds ratio (OR) and 95 % confidence intervals (95 % CIs) of colorectal cancer risk after adjusting for various confounders.Results
A strong inverse association was found between β-cryptoxanthin intake and colorectal cancer risk. Compared with the lowest quartile, the highest quartile intake showed a risk reduction of 77 % (OR 0.23, 95 % CI 0.17–0.33, P trend < 0.01) after adjustment for various confounding variables. The inverse associations were also observed for α-carotene (OR 0.50, 95 % CI 0.37–0.68, P trend < 0.01), β-carotene (OR 0.67, 95 % CI 0.49–0.91, P trend < 0.01), and lycopene (OR 0.51, 95 % CI 0.37–0.70, P trend < 0.01). There was no statistically significant association between lutein/zeaxanthin intake and colorectal cancer risk. These findings were consistent across cancer site, sources of controls, and smoking status. The inverse associations between dietary α-carotene, β-cryptoxanthin, and lycopene intake and colorectal cancer risk were found in both males and females, while inverse associations between β-carotene intake and colorectal cancer risk were only observed in males.Conclusions
Consumption of α-carotene, β-carotene, β-cryptoxanthin, and lycopene was inversely associated with colorectal cancer risk. No significant association was found between lutein/zeaxanthin intake and colorectal cancer risk.107.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2022,32(9):2137-2146
Background and aimsLeptin is an adipocyte-derived peptide involved in energy homeostasis and body weight regulation. The position of leptin in cardiovascular pathophysiology remains controversial. Some studies suggest a detrimental effect of hyperleptinemia on the cardiovascular (CV) system, while others assume the role of leptin as a neutral or even protective factor. We have explored whether high leptin affects the mortality and morbidity risk in patients with stable coronary heart disease.Methods and resultsWe followed 975 patients ≥6 months after myocardial infarction or coronary revascularization in a prospective study. All-cause or cardiovascular death, non-fatal cardiovascular events (recurrent myocardial infarction, stroke, or any revascularization), and hospitalizations for heart failure (HF) we used as outcomes.High serum leptin concentrations (≥18.9 ng/mL, i.e., 4th quartile) were associated with worse survival, as well as with a higher incidence of fatal vascular events or hospitalizations for HF. Even after full adjustment for potential covariates, high leptin remained to be associated with a significantly increased 5-years risk of all-cause death [Hazard risk ratio (HRR) 2.10 (95%CIs:1.29–3.42), p < 0.003], CV death [HRR 2.65 (95%CIs:1.48–4.74), p < 0.001], and HF hospitalization [HRR 1.95 (95% CIs:1.11–3.44), p < 0.020]. In contrast, the incidence risk of non-fatal CV events was only marginally and non-significantly influenced [HRR 1.27 (95%CIs:0.76–2.13), p = 0.359].ConclusionsHigh leptin concentration entails an increased risk of mortality, apparently driven by fatal CV events and future worsening of HF, on top of conventional CV risk factors and the baseline status of left ventricular function. 相似文献
108.
《HPB : the official journal of the International Hepato Pancreato Biliary Association》2022,24(10):1592-1599
BackgroundRandomized trials have compared laparoscopic pancreatoduodenectomy (LPD) to open pancreatoduodenectomy (OPD) with conflicting results. An IPDMA may give more insight into the differences between LPD and OPD, and could identify high-risk subgroups.MethodsA systematic literature search was performed in the Pubmed, Embase, and the Cochrane library databases (October 2019). Out of 1410 studies, three randomized trials were identified. Primary outcome was major complications (Clavien-Dindo grade ≥ III). Subgroup analyses were performed for high-risk subgroups including patients with BMI of ≥25 kg/m2, pancreatic duct <3 mm, age ≥70 years, and malignancy.ResultsData from 224 patients were collected. After LPD, major complications occurred in 33/114 (29%) patients compared to 34/110 (31%) patients after OPD (adjusted odds ratio (OR) 0.62; 95% confidence interval (CI) 0.3–1.4, P = 0.257). No differences were seen for major complications and 90-day mortality LPD 8 (7%) vs OPD 4 (4%) (adjusted OR 0.2; 95% CI 0.02–1.3, P = 0.080). With LPD, operative time was longer (420 vs 318 min, p < 0.001) and hospital stay was shorter (mean difference ?6.97 days). Outcomes remained stable in the high-risk subgroups.ConclusionLPD did not reduce the rate of major postoperative complications as compared to OPD. LPD increased operative time and shortened hospital stay with 7 days. 相似文献
109.
《HPB : the official journal of the International Hepato Pancreato Biliary Association》2022,24(9):1453-1463
BackgroundExperimental evidence suggests sex dependent differences in liver regeneration. Limited evidence is available examining sex differences in post-hepatectomy liver failure (PHLF) and postoperative outcomes. Our aim was to assess the influence of sex on the outcomes after liver resection.MethodsThe hepatectomy targeted National Surgical Quality Improvement Program (NSQIP) database was assessed for associations between sex and outcomes.ResultsA total of 13,401 patients underwent elective hepatic resection between 2014-2017. PHLF was highest among male patients with hepatocellular carcinoma (HCC) (OR = 2.81,95%CI:1.40–5.62). Male sex was independently associated with increased PHLF (OR = 1.47,95%CI:1.15–1.88), major complications (OR = 1.25,95%CI:1.08–1.45), mortality (OR = 1.61,95%CI:1.03–2.50), and if only major resections were assessed (OR = 1.38,95%CI:1.03–1.84). Diagnosis specific subgroup analyses revealed that effects of sex were predominantly HCC associated.ConclusionsThis is the largest series investigating the effects of gender on outcomes after hepatic resection. We documented that women undergoing liver resection have significantly lower risk of PHLF. This difference seemed influenced by the striking increase of PHLF in male HCC patients. These hypothesis suggest that sex might play a role in preoperative risk stratification. 相似文献
110.
Li CX Xu GL Jiang ZY Li JJ Luo GY Shan HB Zhang R Li Y 《World journal of gastroenterology : WJG》2004,10(15):2201-2204
AIM: To evaluate the clinical effect of high-intensity focused ultrasound (HIFU) in the treatment of patients with liver cancer. METHODS: HIFU treatment was performed in 100 patients with liver cancer under general anesthesia and by a targeted ultrasound. Evaluation of efficacy was made on the basis of clinical symptoms, liver function tests, AFP, MRI or CT before and after the treatment. RESULTS: After HIFU treatment, clinical symptoms were relieved in 86.6%(71/82) of patients. The ascites disappeared in 6 patients. ALT (95+/-44) U/L and AST (114+/-58) U/L before HIFU treatment were reduced to normal in 83.3%(30/36) and 72.9%(35/48) patients, respectively, after the treatment. AFP was lowered by more than 50% in 65.3%(32/49) patients. After HIFU treatment, MRI or CT findings indicated coagulation necrosis and blood supply reduction or disappearance of tumor in the target region. CONCLUSION: HIFU can efficiently treat the patients with liver cancer. It will offer a significant noninvasive therapy for local treatment of liver tumor. 相似文献